Peer Review reports
From: The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease
| Original Submission | ||
|---|---|---|
| 13 Sep 2018 | Submitted | Original manuscript |
| 23 Oct 2018 | Reviewed | Reviewer Report - Matthew R. Weir |
| 2 Dec 2018 | Reviewed | Reviewer Report - Elaine Ku |
| 9 Dec 2018 | Reviewed | Reviewer Report - Navin Jaipaul |
| 8 Jan 2019 | Author responded | Author comments - Marc Evans |
| Resubmission - Version 2 | ||
| 8 Jan 2019 | Submitted | Manuscript version 2 |
| 18 Jan 2019 | Author responded | Author comments - Marc Evans |
| Resubmission - Version 3 | ||
| 18 Jan 2019 | Submitted | Manuscript version 3 |
| 22 Jan 2019 | Author responded | Author comments - Marc Evans |
| Resubmission - Version 4 | ||
| 22 Jan 2019 | Submitted | Manuscript version 4 |
| Publishing | ||
| 24 Jan 2019 | Editorially accepted | |
| 31 Jan 2019 | Article published | 10.1186/s12882-019-1228-y |
You can find further information about peer review here.